510(k) Report

510(k) · Cleared

Cleared

Oncentra Prostate 4.0

K112420510(k) TraditionalCleared Nov 18, 201187-day reviewClass II21 CFR 892.5700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nucletron · JAQ System, Applicator, Radionuclide, Remote-Controlled

Cleared on Nov 18, 2011 as substantially equivalent to K022741 (Nucletron Corporation, 2002) and 1 other predicate after an 87-day review. Its family tree reaches back 4 generations to 1991. 1 later device descends from it.

Decided
Nov 18, 2011
Review
87 days
Class
Class II
Product code
JAQ
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to K911612 (1991). 6 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 4 generations backK911612 Nucletron Planning SystemNucletron-Oldelft Corp. · 1991
  2. 3 generations backK992303 Sonographic Planning of Oncology Treatments (Spot), Model V.. 1.0Nucletron Corp. · 2000
  3. 2 generations backK022739 Real Time HDR (220V), Model 132.001; Real Time HDR (110V), Model…Nucletron Corporation · 2002
  4. 1 generation backK031158 Swift 2.0, Model 132.001Nucletron Corp. · 2003
  5. This deviceK112420 Oncentra Prostate 4.0Nucletron · 2011
  6. Descendant · cites it directly · 0 of its ownK170841 BiopSee, Mobile USMedcom GmbH · 2017

Most influential descendants

Showing 1 of 1 · See all
  • K170841BiopSee, Mobile USMedcom GmbH · 2017 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K911612Nucletron Planning SystemNucletron-Oldelft Corp.1991—
−3K992303Sonographic Planning of Oncology Treatments (Spot), Model V.. 1.0Nucletron Corp.2000—
−2K022739Real Time HDR (220V), Model 132.001; Real Time HDR (110V), Model 132.002Nucletron Corporation2002—
−1K031158Swift 2.0, Model 132.001Nucletron Corp.2003—
0 (this device)K112420Oncentra Prostate 4.0Nucletron2011—
+1K170841BiopSee, Mobile USMedcom GmbH2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
200210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201710
FIG. 1 — Lineage of K112420, 1991–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAQ device

  1. #1 K241853 Titanium Fletcher-Style Applicator Set Defined…score 14.9 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K022741Spot Pro (220V), Model 131.099
Summary page 1
…in the table below: ~ ~+A~eieett~tY~21~ ~I~50(k) U Nulern V Spot Pro K022741 Nulern V Swift 2.0 K031158 Traditional 51 0(k)…
Nucletron Corporation2002—
*K031158Swift 2.0, Model 132.001
Summary page 1
…~I~50(k) U Nulern V Spot Pro K022741 Nulern V Swift 2.0 K031158 Traditional 51 0(k) Page 33 Nucletron Onc…
Nucletron Corp.2003—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K170841BiopSee, Mobile USMedcom GmbH20170

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 4 companies; a new generation was cleared every 8.3 years on median.
  • None of the 6 ancestors has a recall.
  • Of its descendants, K170841 (Medcom GmbH, 2017) has gone furthest, with 0 descendants of its own.

How does its category compare?

All JAQ devices

JAQ System, Applicator, Radionuclide, Remote-Controlled: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · JAQ

6in 2025

2007: 112008: 102009: 102010: 22011: 22012: 72013: 62014: 72015: 112016: 62017: 72018: 72019: 22020: 42022: 12023: 22024: 102025: 62026 (partial year): 2
2007high 11 (2007) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAQ

91in 2025

2007: 48 days median2008: 34 days median2009: 27 days median2012: 89 days median2013: 100 days median2014: 116 days median2015: 183 days median2016: 154 days median2017: 229 days median2018: 252 days median2020: 62 days median2024: 126 days median2025: 91 days median
2007high 252 (2018) · low 27 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JAQ

1in 2019

2008: 52009: 12010: 22011: 132012: 52013: 12019: 12026 (partial year): 3
2007high 13 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JAQ

3in 2025

2007: 132008: 322009: 352010: 362011: 422012: 342013: 432014: 182015: 72016: 32017: 52018: 22019: 82020: 82021: 52022: 52023: 32024: 12025: 3
2007high 43 (2013) · low 1 (2024)2025

MAUDE reports naming product code JAQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071148013
20081034532
20091027135
20102—236
20112—1342
2012789534
20136100143
20147116018
20151118307
2016615403
2017722905
2018725202
20192—18
202046208
20210—05
20221—05
20232—03
20241012601
202569103
20262—3—

What is it indicated for?

Oncentra Prostate is a software application intended for use with Brachytherapy. procedures, i.e. intercavitary, interstitial, intraluminal, involving radioactive sources The software should only be used by a person trained in brachytherapy techniques (such a person will be referred to as the user).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K112420: Oncentra Prostate 4.0.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K112420

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026